These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 22379033)
1. MicroRNA-deficient NK cells exhibit decreased survival but enhanced function. Sullivan RP; Leong JW; Schneider SE; Keppel CR; Germino E; French AR; Fehniger TA J Immunol; 2012 Apr; 188(7):3019-30. PubMed ID: 22379033 [TBL] [Abstract][Full Text] [Related]
2. NKp46-mediated Dicer1 inactivation results in defective NK-cell differentiation and effector functions in mice. Degouve S; Tavares A; Viel S; Walzer T; Marçais A Eur J Immunol; 2016 Aug; 46(8):1902-11. PubMed ID: 27195970 [TBL] [Abstract][Full Text] [Related]
3. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. Orange JS; Wang B; Terhorst C; Biron CA J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678 [TBL] [Abstract][Full Text] [Related]
4. Cytokine-Mediated Activation of NK Cells during Viral Infection. Freeman BE; Raué HP; Hill AB; Slifka MK J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253 [TBL] [Abstract][Full Text] [Related]
5. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778 [TBL] [Abstract][Full Text] [Related]
6. DICER1 is essential for survival of postmitotic rod photoreceptor cells in mice. Sundermeier TR; Zhang N; Vinberg F; Mustafi D; Kohno H; Golczak M; Bai X; Maeda A; Kefalov VJ; Palczewski K FASEB J; 2014 Aug; 28(8):3780-91. PubMed ID: 24812086 [TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus. Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development. Constantin L; Constantin M; Wainwright BJ Genetics; 2016 Mar; 202(3):1105-18. PubMed ID: 26773048 [TBL] [Abstract][Full Text] [Related]
9. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Zawislak CL; Beaulieu AM; Loeb GB; Karo J; Canner D; Bezman NA; Lanier LL; Rudensky AY; Sun JC Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6967-72. PubMed ID: 23572582 [TBL] [Abstract][Full Text] [Related]
10. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. Orange JS; Biron CA J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121 [TBL] [Abstract][Full Text] [Related]
11. Dicer1 deletion in myeloid-committed progenitors causes neutrophil dysplasia and blocks macrophage/dendritic cell development in mice. Alemdehy MF; van Boxtel NG; de Looper HW; van den Berge IJ; Sanders MA; Cupedo T; Touw IP; Erkeland SJ Blood; 2012 May; 119(20):4723-30. PubMed ID: 22353998 [TBL] [Abstract][Full Text] [Related]
12. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. Tassi I; Presti R; Kim S; Yokoyama WM; Gilfillan S; Colonna M J Immunol; 2005 Jul; 175(2):749-54. PubMed ID: 16002670 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways. Sullivan RP; Fogel LA; Leong JW; Schneider SE; Wong R; Romee R; Thai TH; Sexl V; Matkovich SJ; Dorn GW; French AR; Fehniger TA J Immunol; 2013 Dec; 191(12):5904-13. PubMed ID: 24227772 [TBL] [Abstract][Full Text] [Related]
14. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. Salazar-Mather TP; Hamilton TA; Biron CA J Clin Invest; 2000 Apr; 105(7):985-93. PubMed ID: 10749577 [TBL] [Abstract][Full Text] [Related]